2.27 USD
▲+0.03+2.25%
2026-08-03
市值
$225.19M
市盈率
—
EPS
-0.82
股息率
—
52 周区间
2.03 – 4.00
成交量
106.02K
Beta
1.56
目标价
8.61
52W 低 2.0352W 高 4.00
价格走势
公司简介
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company’s SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It develops Crenezumab, a humanized, conformation specific monoclonal antibody used to slow A...